GLP-1 Landing Page — What Makes Telehealth Weight Loss Pages Convert

The GLP-1 landing page is the most underestimated lever in telehealth paid social. Brands obsess over creative and audience targeting while running the same landing page they shipped 18 months ago at 7% conversion. Lifting that page to 12-14% is a 75-100% effective CAC reduction at constant ad spend — a larger swing than any creative test will produce in the same quarter.

Here is what makes a GLP-1 landing page convert in 2026, what to test first, and what to stop doing.

The Above-the-Fold Elements That Determine Everything

The viewer makes a continue-or-leave decision in roughly 3-5 seconds on mobile. Above-the-fold must communicate: what the medication is (compounded semaglutide, brand-name tirzepatide, etc.), what the entry-level price is (with subscription terms visible), what the provider relationship looks like (licensed clinician, not "wellness coach"), and a single CTA that maps to the next step.

Pages that miss any one of these four elements above the fold lose 20-40% of paid traffic before the first scroll. The single most common miss in 2026 is pricing transparency — brands try to drive the viewer into a quiz funnel before revealing price, which trains the savvy paid social audience to bounce.

The Qualification Gate Decision

Two structural options: pre-consultation qualification (viewer answers BMI, contraindication, and state questions before booking) or post-consultation qualification (viewer books a consultation; provider qualifies on the call).

Pre-consultation qualification produces higher consultation-to-purchase conversion (50-65% vs. 35-45%) because unqualified viewers self-deselect. The trade-off: lower top-of-funnel conversion (8-12% LP-to-consultation vs. 10-15%). Net unit economics favor pre-consultation qualification for compounded GLP-1; post-consultation can win for brand-name where the qualification gate is more nuanced.

For the broader funnel math, see the weight loss sales funnel breakdown.

Pricing Transparency Without Killing Conversion

The standard worry: showing the full subscription price above the fold will kill conversion. The data contradicts this. Pages that hide pricing convert better in the LP-to-consultation step (by 15-25%) but worse in consultation-to-purchase (by 30-50%) because the audience hits a price they did not expect at the worst possible moment.

Net fully-loaded CAC is consistently lower with transparent pricing. The fix is framing — show entry price, show what is included (medication, provider time, ongoing support), and show the comparable retail price for context. Pricing-only without context loses; pricing-in-context wins.

Trust Signals That Actually Move Conversion

Provider credentialing with named clinicians and state license context. Generic "board-certified physicians" language underperforms named, photographed providers with explicit credentials.

Pharmacy / supply chain identification. Branded pharmacy partners, 503A/503B status where relevant, and shipping logistics. The audience has been burned by sketchy compounders and reads pharmacy identity as a quality signal.

Real patient stories with named individuals, compliance-aligned framing, and a clear consent paragraph. Stock-photo testimonials underperform by 30-50%. For the framework, see telehealth landing pages for paid social.

Quiz Funnel vs. Direct Consultation Routing

Quiz funnels (5-8 question intake before booking) work for brand-name GLP-1 where qualification is genuinely complex and the audience expects the deliberate path. They underperform for compounded GLP-1 where the audience is price-sensitive and reads multi-step funnels as friction.

The test that matters: A/B route 50% of traffic to a 5-question quiz and 50% to a direct consultation booking. Measure both LP-to-consultation and consultation-to-purchase, then pick the structure with better fully-loaded CAC. Most brands skip this test because the quiz is "what everyone is doing" and miss 15-25% conversion lift available.

Tests That Move the Number

Hero copy test: outcome framing vs. process framing vs. provider framing. Three variants, two-week test, 95% confidence. Compounded GLP-1 usually wins with provider framing; brand-name usually wins with outcome framing.

CTA copy test: "Start your consultation" vs. "Check if I qualify" vs. "See pricing". Pricing-anchored CTAs underperform on top-of-funnel conversion but overperform on fully-loaded CAC. Measure the downstream step, not the click.

Above-the-fold layout test: hero image vs. provider video vs. before/after framing where compliant. Provider video has the highest conversion lift for trust-sensitive audiences (older demographics, brand-name GLP-1).

Mobile-specific test: sticky CTA vs. embedded CTA. Sticky CTA lifts mobile conversion 8-15% on average. This is one of the highest-leverage and lowest-effort tests in the GLP-1 landing page playbook.

What to Stop Doing

Stop running ad-creative landing pages that look like ad accounts (hero stat + arrow + countdown timer). The 2024 high-pressure landing page aesthetic is a flag for both platform reviewers and the modern GLP-1 buyer.

Stop hiding subscription terms. FTC scrutiny of subscription telehealth is sharpening in 2026, and Meta and Google reviewers increasingly check pricing transparency. Hidden terms are a present compliance risk, not a future one.

Stop running the same landing page for cold and retargeting traffic. Cold needs trust-building above the fold; retargeting needs friction reduction and CTA prominence. The performance gap from segmenting these is 20-35%.

The Operator Summary

The GLP-1 landing page is the most underinvested optimization surface in telehealth weight loss. Above-the-fold clarity, transparent pricing in context, real trust signals, and disciplined A/B testing move conversion from 6-8% to 12-14% inside a quarter — and that lift compounds against every dollar of paid social spend. Fix the page before you fund the next creative sprint.